814 / 1456
•
Further research is necessary to assess the survival outcome
and late toxicity with a longer follow-up for oligometastatic
NSCLC
•
Different strategies such as 4D repiratory gated acquisition
techniques are needed for tumor motion control
•
The consecuences of lower doses (“bath dose”) in the OAR is
still unknown